Maria Frantzi

1.6k total citations
49 papers, 1.1k citations indexed

About

Maria Frantzi is a scholar working on Spectroscopy, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Maria Frantzi has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Spectroscopy, 22 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Maria Frantzi's work include Advanced Proteomics Techniques and Applications (28 papers), Bladder and Urothelial Cancer Treatments (15 papers) and Prostate Cancer Treatment and Research (14 papers). Maria Frantzi is often cited by papers focused on Advanced Proteomics Techniques and Applications (28 papers), Bladder and Urothelial Cancer Treatments (15 papers) and Prostate Cancer Treatment and Research (14 papers). Maria Frantzi collaborates with scholars based in Germany, Greece and United Kingdom. Maria Frantzi's co-authors include Agnieszka Latosińska, Harald Mischak, Antonia Vlahou, Akshay Bhat, Axel S. Merseburger, Manousos Makridakis, Justyna Siwy, Jérôme Zoidakis, Jochen Metzger and William Mullen and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and British Journal of Cancer.

In The Last Decade

Maria Frantzi

47 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Frantzi Germany 19 509 353 242 222 160 49 1.1k
Agnieszka Latosińska Germany 23 635 1.2× 385 1.1× 224 0.9× 210 0.9× 163 1.0× 80 1.4k
Chien‐Lun Chen Taiwan 17 547 1.1× 251 0.7× 324 1.3× 331 1.5× 203 1.3× 70 1.2k
Anthea J. Stanley United Kingdom 15 536 1.1× 275 0.8× 237 1.0× 58 0.3× 225 1.4× 21 851
Evelyn Zeindl‐Eberhart Germany 18 655 1.3× 190 0.5× 143 0.6× 89 0.4× 142 0.9× 22 1.2k
Jinong Li United States 8 1.3k 2.5× 1.0k 2.9× 92 0.4× 71 0.3× 270 1.7× 9 1.8k
Christine Yip United States 13 520 1.0× 409 1.2× 82 0.3× 78 0.4× 160 1.0× 38 968
David K. Crockett United States 22 619 1.2× 221 0.6× 85 0.4× 73 0.3× 91 0.6× 49 1.2k
Daniel W. Wilkey United States 19 749 1.5× 53 0.2× 142 0.6× 82 0.4× 236 1.5× 43 1.2k
Donna Badgwell United States 13 597 1.2× 84 0.2× 112 0.5× 199 0.9× 325 2.0× 18 1.5k
Tedros Bezabeh Canada 21 525 1.0× 108 0.3× 117 0.5× 96 0.4× 128 0.8× 37 976

Countries citing papers authored by Maria Frantzi

Since Specialization
Citations

This map shows the geographic impact of Maria Frantzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Frantzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Frantzi more than expected).

Fields of papers citing papers by Maria Frantzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Frantzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Frantzi. The network helps show where Maria Frantzi may publish in the future.

Co-authorship network of co-authors of Maria Frantzi

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Frantzi. A scholar is included among the top collaborators of Maria Frantzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Frantzi. Maria Frantzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gómez‐Gómez, Enrique, Bartosz Małkiewicz, Antonia Vlahou, et al.. (2025). Omics-Mediated Treatment for Advanced Prostate Cancer: Moving Towards Precision Oncology. International Journal of Molecular Sciences. 26(15). 7475–7475.
2.
Frantzi, Maria, et al.. (2025). The impact of urine biomarkers for prostate cancer detection–A systematic state of the art review. Critical Reviews in Oncology/Hematology. 210. 104699–104699. 1 indexed citations
3.
Frantzi, Maria, Zoran Čulig, Isabel Heidegger, et al.. (2023). Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination. Cancers. 15(4). 1166–1166. 15 indexed citations
4.
Frantzi, Maria, Isabel Heidegger, Enrique Gómez‐Gómez, et al.. (2022). Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer. World Journal of Urology. 40(9). 2195–2203. 8 indexed citations
5.
Bannaga, Ayman, Jochen Metzger, Torsten Voigtländer, et al.. (2021). Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma. Cancers. 13(15). 3786–3786. 7 indexed citations
6.
Latosińska, Agnieszka, Katarina Davalieva, Manousos Makridakis, et al.. (2020). Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation. Diagnostics. 10(9). 655–655. 15 indexed citations
7.
Frantzi, Maria, Enrique Gómez‐Gómez, & Harald Mischak. (2020). Noninvasive biomarkers to guide intervention: toward personalized patient management in prostate cancer. Expert Review of Precision Medicine and Drug Development. 5(5). 383–400. 5 indexed citations
8.
Voigtländer, Torsten, Jochen Metzger, Holger Husi, et al.. (2020). Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma. Journal of Biomedical Science. 27(1). 13–13. 24 indexed citations
9.
Frantzi, Maria, et al.. (2020). Monte Carlo Deep Neural Network Model for Spread and Peak Prediction of COVID-19. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 4 indexed citations
10.
Krochmal, Magdalena, Kim E.M. van Kessel, Ellen C. Zwarthoff, et al.. (2019). Urinary peptide panel for prognostic assessment of bladder cancer relapse. Scientific Reports. 9(1). 7635–7635. 14 indexed citations
11.
Latosińska, Agnieszka, Jochen Metzger, David Marx, et al.. (2018). Proteomics biomarkers for solid tumors: Current status and future prospects. Mass Spectrometry Reviews. 38(1). 49–78. 50 indexed citations
12.
Latosińska, Agnieszka, Justyna Siwy, Jochen Metzger, et al.. (2018). Urinary CE-MS peptide marker pattern for detection of solid tumors. Scientific Reports. 8(1). 5227–5227. 28 indexed citations
13.
Marx, David, Jochen Metzger, Martin Pejchinοvski, et al.. (2017). Proteomics and Metabolomics for AKI Diagnosis. Seminars in Nephrology. 38(1). 63–87. 65 indexed citations
14.
Latosińska, Agnieszka, Manousos Makridakis, William Mullen, et al.. (2017). Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention. Oncotarget. 8(41). 69435–69455. 30 indexed citations
15.
Frantzi, Maria, Agnieszka Latosińska, Marie C. Hupe, et al.. (2015). Developing proteomic biomarkers for bladder cancer: towards clinical application. Nature Reviews Urology. 12(6). 317–330. 66 indexed citations
16.
Frantzi, Maria, Akshay Bhat, & Agnieszka Latosińska. (2014). Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development. Clinical and Translational Medicine. 3(1). 7–7. 100 indexed citations
17.
Frantzi, Maria, Jérôme Zoidakis, Theofilos Papadopoulos, et al.. (2013). IMAC Fractionation in Combination with LC–MS Reveals H2B and NIF-1 Peptides As Potential Bladder Cancer Biomarkers. Journal of Proteome Research. 12(9). 3969–3979. 18 indexed citations
18.
Frantzi, Maria, Jochen Metzger, Rosamonde E. Banks, et al.. (2013). Discovery and validation of urinary biomarkers for detection of renal cell carcinoma. Journal of Proteomics. 98. 44–58. 54 indexed citations
19.
Frantzi, Maria, Manousos Makridakis, & Antonia Vlahou. (2012). Biomarkers for bladder cancer aggressiveness. Current Opinion in Urology. 22(5). 390–396. 31 indexed citations
20.
Zoidakis, Jérôme, Manousos Makridakis, Panagiotis Zerefos, et al.. (2011). Profilin 1 is a Potential Biomarker for Bladder Cancer Aggressiveness. Molecular & Cellular Proteomics. 11(4). M111.009449–M111.009449. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agnieszka Latosińska Breakdown of academic impact, for papers by Chien‐Lun Chen Breakdown of academic impact, for papers by Anthea J. Stanley Breakdown of academic impact, for papers by Evelyn Zeindl‐Eberhart Breakdown of academic impact, for papers by Jinong Li Breakdown of academic impact, for papers by Christine Yip Breakdown of academic impact, for papers by David K. Crockett Breakdown of academic impact, for papers by Daniel W. Wilkey Breakdown of academic impact, for papers by Donna Badgwell Breakdown of academic impact, for papers by Tedros Bezabeh
Rankless by CCL
2026